Display Settings:

Format

Send to:

Choose Destination
    Am J Med Sci. 2009 Dec;338(6):481-5.

    Prognostic factors in idiopathic pulmonary fibrosis.

    Source

    Fourth Respiratory Medicine Department, Athens Chest Disease Hospital Sotiria, Athens, Greece. tzilasvasilios@yahoo.gr

    Abstract

    Idiopathic pulmonary fibrosis, 1 of the 7 idiopathic interstitial pneumonias, carries an ominous prognosis. It has a median survival of 2.8 years. However, there is significant heterogeneity in the actual length of survival, which varies from months to >5 years. Unfortunately, in addition to lung transplantation, no known medical intervention alters the natural history of the disease. Currently, many phase-III clinical trials are ongoing, but there is no Federal Drug Administration approved therapy. Thus, it is important for the clinician to be able to evaluate prognostic factors. These will help him draw conclusions about the possible course of his idiopathic pulmonary fibrosis patients and make important therapeutic decisions (lung transplantation).

    PMID:
    19826245
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk